Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
St. Olavs Hospital
Age
18–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically verified breast carcinoma or colorectal carcinoma
2 or multiple liver metastases
considered eligible by a consulting oncologist for first line treatment with chemotherapy in the group of taxanes (patients with breast cancer) or the combination regimen FOLFIRI (patients with colorectal carcinoma)
Signed informed consent and expected cooperation of the patients for the treatment and follow up must be obtained and documented according to ICH GCP, and national/local regulations
You may not be if
Known contraindications for ultrasound contrast-enhancement agent Sonovue® (Bracco)
Hematological bleeding status before experimental treatment: Hb \< 8g/dL, trc \< 80 x109/l, APTT˃ 45s, INR ˃ 1,5
Considered eligible for surgical removal of liver metastases
